Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
Flowering plants are the most successful land plants because theri seeds are protected in fruits
Answer:
mRNA is “messenger” RNA. mRNA is synthesized in the nucleus using the nucleotide sequence of DNA as a template. This process requires nucleotide triphosphates as substrates and is catalyzed by the enzyme RNA polymerase II. The process of making mRNA from DNA is called transcription, and it occurs in the nucleus.
I think about 60 g/m^2 is released into the atmosphere as a result of the metabolic activity of herbivores. Metabolism is the sum of the chemical reactions that take place within a cell of a living organisms and that provide energy energy for vital processes and also for synthesizing new organic material. In herbivores, cellular respiration is the major process that releases carbon dioxide in the atmosphere.
